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Porcine reproductive and respiratory syndrome is a major cause of economic loss for the swine
industry worldwide. Porcine reproductive and respiratory syndrome virus (PRRSV) triggers weak
and atypical innate immune responses, but key genes and mechanisms by which the virus
interferes with the host innate immunity have not yet been elucidated. In this study, genes that
control the response of the main target of PRRSV, porcine alveolar macrophages (PAMs), were
profiled in vitro with a time-course experiment spanning the first round of virus replication. PAMs
were obtained from six piglets and challenged with the Lelystad PRRSV strain, and gene
expression was investigated using Affymetrix microarrays and real-time PCR. Of the 1409
differentially expressed transcripts identified by analysis of variance, two, five, 25, 16 and 100
differed from controls by a minimum of 1.5-fold at 1, 3, 6, 9 and 12 h post-infection (p.i.),
respectively. A PRRSV infection effect was detectable between 3 and 6 h p.i., and was
characterized by a consistent downregulation of gene expression, followed by the start of the host
innate immune response at 9 h p.i. The expression of beta interferon 1 (IFN-b), but not of IFN-a,
was strongly upregulated, whilst few genes commonly expressed in response to viral infections
and/or induced by interferons were found to be differentially expressed. A predominance of
anti-apoptotic transcripts (e.g. interleukin-10), a shift towards a T-helper cell type 2 response and
a weak upregulation of tumour necrosis factor-a expression were observed within 12 h p.i.,
reinforcing the hypotheses that PRRSV has developed sophisticated mechanisms to escape the
host defence.
INTRODUCTION
Porcine reproductive and respiratory syndrome is a major
cause of economic loss for the swine industry worldwide
(Neumann et al., 2005) and causes high mortality of nursery
piglets, reproductive failure in sows, respiratory distress in
pigs of all ages and influenza-like symptoms in grow/finish
swine (Mengeling & Lager, 2000; Nodelijk, 2002). The
aetiological agent is porcine reproductive and respiratory
syndrome virus (PRRSV), belonging to the family
Arteriviridae with an enveloped, positive-stranded RNA
genome of about 14.5 kb (Snijder & Meulenberg, 1998).
A typical hallmark of PRRSV is that it causes an acute
viraemic phase (up to 14 days post-inoculation) during
which the virus can be detected in serum and all susceptible
organs (Beyer et al., 2000; Duan et al., 1997b). This acute
phase is followed by virus elimination from serum and
most organs, and by persistent replication in tonsils, lungs
and some lymph nodes (Allende et al., 2000; Rowland et al.,
2003; Wills et al., 2003). This prolonged replication does
not represent a true persistent infection, as all animals clear
the virus by 6 months after inoculation, thus indirectly
showing that the immune system is capable of finally
dealing with the virus, although not efficiently. Because of
this persistent nature of PRRSV infections, numerous
studies have analysed the immune responses that may
control PRRSV infections or that may be altered by PRRSV
(reviewed by Lopez & Osorio, 2004; Mateu & Diaz, 2007;
Murtaugh et al., 2002).
The PRRSV-specific humoral immunity is generally
characterized by a strong, non-neutralizing antibody
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(p.i.). In contrast, induction of neutralizing antibodies is
severely delayed (starting at 3–4 weeks p.i.) and their levels
remain low (Lopez & Osorio, 2004); antibodies were
shown to be ineffective in eliminating PRRSV-infected
macrophages in combination with complement (Costers
et al., 2006). Cellular immune responses against PRRSV
infection are characterized by a late onset of lymphocyte
proliferative responses (4 weeks p.i.) and the late appear-
ance of gamma interferon (IFN-c)-secreting cells (Meier
et al., 2003). Several studies have also shown weak and
atypical innate immune responses, such as weak IFN-a
responses and high induction of interleukin (IL)-10. This
inadequate recognition of virus infection by the innate
defence mechanisms could be responsible for the initially
crippled immune response (Albina et al., 1998; Buddaert
et al., 1998; Murtaugh et al., 2002; Royaee et al., 2004;
Suradhat et al., 2003; van Reeth et al., 1999; Xiao et al.,
2004). The mechanism by which PRRSV interferes with
innate immune responses has yet to be elucidated.
PRRSV has a highly specific tropism for cells of the
monocyte/macrophage lineage, cells that are essential for
immune function. In vivo, the virus mainly infects a
subpopulation of differentiated macrophages that are
present in tonsils, lungs and other lymphoid tissues
(Beyer et al., 2000; Duan et al., 1997a, b). Besides
macrophages, in vitro analysis of susceptible cells has
identified cultivated monocytes and dendritic cells as
potential targets, but their role during PRRSV infections
in vivo remains to be established (Delputte et al., 2007;
Duan et al., 1997a; Loving et al., 2007; Teifke et al., 2001;
Voicu et al., 1994; Wang et al., 2007). Lung pathogenesis is
another feature of PRRSV infections, and porcine alveolar
macrophages (PAMs) are generally considered to be a
major target for PRRSV.
The aim of this study was to gain insight into the putative
mechanisms by which PRRSV can evade innate immunity,
and consequently the adaptive response, using a genome-
wide approach. A time-course gene expression profiling of
PAMs infected in vitro with a reference strain (Lelystad)
was conducted by utilizing an Affymetrix 24K Porcine Chip
microarray. Collection of samples at different times during
the infection cycle, from 1 h p.i. (virus entry) up to 12 h
p.i. (virus release and cell death) allowed us to discriminate
between changes in early and late gene expression during
infection. Times later than 12 h p.i. were not analysed, as
by that time PRRSV infection of macrophages has typically
resulted in cell death.
METHODS
Cells and treatments. Six 3-week-old hybrid piglets from a PRRSV-
and porcine circovirus 2-negative herd of the Rattlerow–Seghers
genetic line (a cross-breed between English Landrace, Belgian
Landrace, Large White and a synthetic company Landrace) were
injected daily with 1 ml enrofloxacin (5% solution) and 1 ml
lincospectin/spectinomycin (5 or 10% solution) for 3 days to
eliminate eventual bacterial pathogens. Two weeks later, the piglets
were sacrificed. PAMs were collected by bronchoalveolar lavage and
frozen in liquid nitrogen as described by Wensvoort et al. (1991).
PAMs were thawed and cultured for 48 h before treatment as
described previously by Delputte & Nauwynck (2004). One primary
culture from each animal was split into two: one was infected at an
m.o.i. of 10 with a 13th passage of PRRSV Lelystad virus (kindly
provided by G. Wensvoort, Institute for Animal Science and Health,
Lelystad, The Netherlands), which was semi-purified as described
previously (Delputte & Nauwynck, 2004). The other culture was
maintained as a control and was mock inoculated. The percentage of
infected cells ranged between 60 and 70% for all batches. Cells were
collected at 1, 3, 6, 9 and 12 h p.i. in TRIzol (Invitrogen Life
Technologies) for RNA extraction (Fig. 1).
RNA extraction, reverse transcription, RNA labelling and cRNA
hybridization. Total RNA extraction from PAMs was performed
using TRIzol following standard instructions (Invitrogen) and a
clean-up was carried out using RNeasy columns (Qiagen). RNA
quality was assessed by microcapillary electrophoresis on an Agilent
2001 Bioanalyser (Agilent Technologies) with RNA 6000 Nanochips.
RNA was quantified by spectrophotometry (ND-1000; NanoDrop
Technologies). Reverse transcription of 20 mg total RNA and synthesis
of biotin-labelled cRNA with one round of amplification were carried
out following the standard Affymetrix one-cycle protocol according
to the manufacturer’s instructions.
Transcriptional profiles were assessed using Affymetrix 24K
GeneChip Porcine Genome Arrays (http://www.affymetrix.com/
products/arrays/specific/porcine.affx). Based on previous evidence
that sample pooling does not significantly affect the results of
Affymetrix chip analysis (see, for example, Han et al., 2004), three
samples each from control and infected-cell cultures were pooled for
Fig. 1. Schematic representation of the experimental design used
in this study to challenge PAMs with PRRSV in vitro. PAMs were
obtained from six piglets (a). Each PAM culture was split into two
and infected with PRRSV or mock infected as a control (b). The
total RNA from PAMs of each piglet was extracted at different time
points (0, 1, 3, 6, 9 and 12 h p.i.). The RNA of three piglets was
pooled (pools I and II) for the subsequent microarray and real-time
analyses (c).
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2 and II
2)
and two infected pools (pools I
+ and II
+).
Hybridization and scanning of the arrays were carried out according
to standard Affymetrix protocols (Shen et al., 2005) using a GeneChip
Scanner 3000 7G.
Microarray data analysis. Signal intensities were evaluated using
the GeneChip Operating Software algorithm (GCOS version 1.4;
Affymetrix). Raw data and statistical analyses were performed with
GeneSpring version 7.3.1 software (Agilent). Normalization was
performed per chip (normalized to 50th percentile) and per gene
(normalized to the median).
A statistical analysis of variance (ANOVA) model was applied to the
data and significance was declared accepting a false discovery rate
(FDR) of 0.05. Fixed effects of time point and status (infected2non-
infected cells) were included in the ANOVA model. A further cut-off
threshold was applied based on a fold change of 1.5 between infected
and control PAMs. Hierarchical clustering of the conditions was
performed using Pearson’s correlation coefficient (r) as a measure of
similarity and the average linkage method as the clustering algorithm.
In order to test for the presence of outliers in the two pools, the
transcriptional profiles of infected animals were analysed separately at
the 3 h p.i. time point. A paired t-test (paired across pools by gene)
was performed using the range of minimum and maximum corrected
expression values within each pool for each gene. The test was applied
(i) to the whole set of genes and (ii) to the subset of genes that
appeared to be significant for differential expression in the general
analysis. No significant difference was observed either for the whole
set of genes included in the study or for the subset of differentially
expressed genes.
The Database for Annotation, Visualization and Integrated Discovery
(DAVID 2006; http://david.abcc.ncifcrf.gov/), an expanded version of
the original web-accessible programs described by Dennis et al.
(2003), was used to allocate transcripts with similar biological
questions into the three gene ontology (GO) categories.
Real-time PCR. Quantitative real-time PCR analysis was conducted
on ten selected swine transcripts and on the ORF7 gene of PRRSV.
Hypoxanthine phosphoribosyltransferase (HPRT1) was chosen as the
reference gene because the amplifications of all control and infected
samples showed very similar threshold cycle (Ct) values (data not
shown). The transcript-specific primers were designed using
ProbeFinder software (version 2.3) on the Roche website (https://
www.roche-applied-science.com/sis/rtpcr/upl/adc.jsp) using standard
settings for the human Universal Probe Library Set catalogue (see
Supplementary Table S1, available with the online version of this
paper).
Two micrograms of total RNA from pools I and II were reverse-
transcribed using the Superscript II RT-PCR System (Invitrogen Life
Technologies) and standard procedures. The real-time reaction
mixture (total 20 ml) included 5 ml cDNA as template (diluted
1:50), 200 nM of each of the two primers (forward and reverse),
100 nM Roche probe and 16 master mix (Applied Biosystems).
Real-time PCR was performed in 384-well optical plates using a Tecan
Freedom EVO-150 liquid handling workstation (Tecan Trading) and
an ABI 7900HT real-time PCR machine (Applied Biosystems) with
the GeneAmp 7900HT sequence detection system software
(PerkinElmer).
A control cDNA dilution series (1:50, 1:100, 1:500 and 1:5000) was
created for each transcript to establish a standard curve for each plate;
real-time reactions of the same pools described for the microarray
analysis were performed in triplicate. Briefly, the log input amount of
the standard curve was plotted against the output Ct values; all
amplifications had a slope of between 23.48 and 22.99 and were
accepted as quantitative. The log input amount of each sample was
then calculated according to the formula (Ct2b)/m, where b is the y-
intercept and m is the slope. The log input amount was converted to
input amount according to the formula 10
log input amount and triplicate
input amounts were averaged for each sample. The mean input
amount of each gene was normalized to the mean input amount of
HPRT1. A t-test (with thresholds for statistical significance set to 0.1
and 0.05) was applied to each gene to verify whether the difference
between control and infected macrophages at each time point was
significant.
Pearson’s correlation coefficient (r) was calculated for each gene on
the normalized data to quantify the consistency between microarray
experiments and real-time PCR.
Microarray data. The data of the microarray analysis were deposited
in the ArrayExpress repository (http://www.ebi.ac.uk/arrayexpress)
with ArrayExpress accession number 6102MEXP-1350, following
the guidelines of the rationale of minimum information about a
microarray experiment (MIAME) (Brazma et al., 2001).
RESULTS
Microarray analysis
ANOVA analysis (FDR50.05) showed that 1409 genes
were differentially expressed in macrophages after PRRSV
infection. After applying a further filter of 1.5-fold change
in expression, two, five, 25, 16 and 100 transcripts were
differentially expressed at 1, 3, 6, 9 and 12 h p.i.,
respectively, compared with the controls at the same time
points. Overall, the effect of PRRSV on the host
transcription machinery was one of downregulation (115/
148 transcripts). The differentially expressed transcripts
were annotated based on a previous work (Tsai et al., 2006)
and are reported in Table 1. The distribution of signal
intensities of the 100 differentially expressed transcripts at
12 h p.i. and the hierarchical clustering of controls and
infected replicates for the five time conditions (plus the
time 0) are shown in Fig. 2.
At early time points (1 and 3 h p.i.), the profiles of gene
expression in the control and infected conditions were very
similar and clustered together, i.e. only two (1 h p.i.) and
five (3 h p.i.) transcripts were significantly altered. The
expression profiles clearly changed between 3 and 6 h p.i.,
with greater differences detected at the later time points (9
and 12 h p.i.), when PRRSV has been shown to complete
its replication (Halbur, 2001; Rossow et al., 1995).
The 6 h p.i. time point was characterized by a consistent
downregulation of gene expression in the infected cells.
The 24 downregulated transcripts represented genes with
functions related to RNA processing (HNRPLL and NXT2),
regulation of biological processes (ATF2, PTPRC, HIF1-a,
DLC1 and RB1CC1) and signal transduction (PLAA,
PTPRC, HIF1-a, DLC1 and GPR160). Only one transcript,
an RNA-dependent helicase (DDX17), was upregulated.
The 9 h p.i. time point was the only one at which most
transcripts (11/16) were upregulated. These represented
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A total of 148 transcripts showed differential expression and are listed from the highest to the lowest fold change at the different time points p.i. The
Affymetrix probe set IDs are reported with fold changes, gene symbols and gene description (Tsai et al., 2006).
Affymetrix probe set ID Fold change Gene symbol Gene description
1 h p.i.
Ssc.10997.1.S1_at 1.699 GRP58 Protein disulfide-isomerase A3 precursor
Ssc.1313.1.A1_at 0.661 NP_077001 XTP3-transactivated protein A (Homo sapiens)
3 h p.i.
Ssc.20199.2.S1_at 0.666 HIVEP2 Human immunodeficiency virus typeI enhancer-binding protein 2
Ssc.30752.1.S1_at 0.659 IFIT1 IFN-induced protein with tetratricopeptide repeats 1
Ssc.23248.1.S1_at 0.653 PTPRC Leukocyte common antigen precursor
AFFX-Ss_IRP_3_at 0.648 IRG6 Sus scrofa inflammatory response protein 6
Ssc.390.2.S1_at 0.550 HIF1-a Hypoxia-inducible factor 1-a
6 h p.i.
Ssc.12512.1.A1_at 1.544 DDX17 Probable RNA-dependent helicase p72 (DEAD-box protein 17)
Ssc.20344.1.S1_at 0.667 WBP2 WW domain-binding protein 2
Ssc.13400.2.S1_at 0.666 C3orf4 Protein C3orf4 (membrane protein GENX-3745) (HSPC174)
Ssc.8570.1.A1_at 0.665 DLC1 Rho-GTPase-activating protein 7
Ssc.13657.1.A1_at 0.663 ATF2 Cyclic-AMP-dependent transcription factor ATF-2
Ssc.16363.1.S1_at 0.662 TMOD3 Ubiquitous tropomodulin
Ssc.3420.1.S1_at 0.660 C14orf111 Protein C14orf111 (CGI-35)
Ssc.7164.1.A1_at 0.660 NP_060530 Mitochondrial isoleucine tRNA synthetase (Homo sapiens)
Ssc.22634.1.S1_at 0.654 RB1CC1 Rb1-inducible coiled coil protein 1 (Homo sapiens)
Ssc.1672.2.A1_at 0.652 HNRPLL Heterogeneous nuclear ribonucleoprotein L-like
Ssc.16335.1.S2_at 0.651 LPL Lipoprotein lipase precursor
Ssc.16422.2.A1_at 0.647 PLAA Phospholipase A-2-activating protein
Ssc.30752.2.A1_at 0.645 IFIT1 IFN-induced protein with tetratricopeptide repeats 1
Ssc.2354.1.S1_at 0.637 GPR160 Probable G protein-coupled receptor 160
Ssc.17091.2.A1_s_at 0.637 C3orf52 TPA-induced transmembrane protein
Ssc.23248.1.S1_at 0.625 PTPRC Leukocyte common antigen precursor
Ssc.1333.1.A1_at 0.611 ZCCHC11 Zinc finger, CCHC domain containing 11 isoform b
Ssc.26084.1.S1_at 0.607 ATP2B1 Plasma membrane calcium-transporting ATPase 1
Ssc.22221.2.S1_at 0.600 GKP3 Glycerol kinase, testis-specific 1
Ssc.13219.1.S1_at 0.599 NP_689905 Core 1 UDP-galactose:N-acetylgalactosamine-a-R b1,3-galact-
osyltransferase 2; core 1 b3-galactosyltransferase-specific
molecular chaperone (Homo sapiens)
Ssc.19975.1.S1_at 0.592 TEBP Telomerase-binding protein p23 (Hsp90 co-chaperone) (proges-
terone receptor complex p23) (Homo sapiens)
Ssc.4004.1.A1_at 0.577 SYNE2 Nesprin 2 (nuclear envelope spectrin repeat protein 2) (Syne-2)
(synaptic nuclear envelope protein 2) (nucleus and actin
connecting element protein) (NUANCE protein)
Ssc.10997.1.S1_at 0.535 GRP58 Protein disulfide-isomerase A3 precursor
Ssc.4472.1.A1_at 0.524 NXT2 NTF2-related export protein 2 (p15-2 protein) (DC9) (BM-025)
Ssc.390.2.S1_at 0.511 HIF1-a Hypoxia-inducible factor 1-a
9 h p.i.
Ssc.30752.2.A1_at 3.195 IFIT1 IFN-induced protein with tetratricopeptide repeats 1
Ssc.5085.1.A1_at 2.794 TNF-aIP3 Tumour necrosis factor, alpha-induced protein 3
Ssc.29006.1.S1_at 2.634 IFN-b1 IFN-b precursor
Ssc.30532.1.A1_at 2.546 XRCC2 DNA-repair protein XRCC2 (X-ray repair cross-complementing
protein 2)
Ssc.286.1.S1_s_at 2.182 cig5 Viperin; similar to inflammatory response protein 6 (Homo
sapiens)
AFFX-Ss_IRP_3_at 1.919 IRG6 Sus scrofa inflammatory response protein 6
Ssc.15761.1.A1_at 1.881 TCRA T-cell receptor a-chain C region (Homo sapiens)
Ssc.314.1.S1_at 1.745 ADM ADM precursor [contains adrenomedullin (AM)]
Ssc.29054.1.A1_at 1.639 GBP1 IFN-induced guanylate-binding protein 1
Ssc.14474.1.S1_at 1.538 LOC396897 Sus scrofa apomucin
Ssc.336.1.S1_at 1.521 USP18 Ubl carboxyl-terminal hydrolase 18
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Affymetrix probe set ID Fold change Gene symbol Gene description
Ssc.11901.1.S1_at 0.652 C10orf22 Chromosome 10 open reading frame 22
Ssc.4462.1.S1_at 0.630 SDHC Succinate dehydrogenase cytochrome b560 subunit, mitochon-
drial precursor (integral membrane protein CII-3)
Ssc.17091.2.A1_s_at 0.621 C3orf52 TPA-induced transmembrane protein
Ssc.5353.1.S1_at 0.620 ZDHHC3 Zinc finger DHHC domain containing protein 3 (zinc finger
protein 373) (DHHC1 protein)
Ssc.15559.1.A1_s_at 0.552 NP_060114 DRE1 protein (Homo sapiens)
12 h p.i.
Ssc.29006.1.S1_at 20.150 IFN-b1 IFN-b precursor
Ssc.30752.2.A1_at 4.917 IFIT1 IFN-induced protein with tetratricopeptide repeats 1
Ssc.30532.1.A1_at 4.079 XRCC2 DNA-repair protein XRCC2 (X-ray repair cross-complementing
protein 2)
AFFX-Ss_IRP_3_at 3.827 IRG6 Sus scrofa inflammatory response protein 6
Ssc.286.1.S1_s_at 3.778 cig5 Viperin; similar to inflammatory response protein 6 (Homo
sapiens)
Ssc.5085.1.A1_at 2.912 TNF-aIP3 Tumour necrosis factor-a-induced protein 3
Ssc.15761.1.A1_at 2.689 TCR-a T-cell receptor a-chain C region (Homo sapiens)
Ssc.336.1.S1_at 2.034 USP18 Ubl carboxyl-terminal hydrolase 18
Ssc.148.1.S1_at 1.934 IL-10 Interleukin-10 precursor
Ssc.12284.1.A1_at 1.923 SGK Serine/threonine-protein kinase Sgk1
Ssc.11048.1.S1_at 1.918 PLAC8 Placenta-specific gene 8 protein
Ssc.16288.1.S1_at 1.859 IGHM Ig a-1 chain C region
Ssc.29054.3.S1_at 1.738 GBP1 IFN-induced guanylate-binding protein 1
Ssc.314.1.S1_at 1.718 ADM ADM precursor [contains adrenomedullin (AM)]
Ssc.18038.1.A1_at 1.642 MAP3K8 Mitogen-activated protein kinase kinase kinase 8
Ssc.10754.1.A1_at 1.621 PIK3R1 Phosphatidylinositol 3-kinase regulatory a subunit (PI3-kinase
p85-alpha subunit)
Ssc.26507.2.S1_at 1.585 NP_073596 Endo-b-N-acetylglucosaminidase (Homo sapiens)
Ssc.25855.1.S1_at 1.531 XP_846553 PREDICTED: hypothetical protein
Ssc.1701.2.S1_at 1.529 Q6PK96 Cytochrome b, ascorbate-dependent 3
Ssc.100.1.S1_at 1.513 TNF-a Tumour necrosis factor precursor (TNF-a)
Ssc.13657.1.A1_at 0.665 ATF2 Cyclic-AMP-dependent transcription factor ATF-2 (activating
transcription factor 2)
Ssc.4498.1.S1_at 0.663 IXL Intersex-like
Ssc.3420.1.S1_at 0.661 C14orf111 Protein C14orf111 (CGI-35)
Ssc.8311.1.A1_at 0.660 MPI Mannose-6-phosphate isomerase
Ssc.8541.1.A1_at 0.659 STAG2 Cohesin subunit SA-2 (Stromal antigen 2)
Ssc.16422.2.A1_at 0.658 PLAA Phospholipase A-2-activating protein
Ssc.21796.1.S1_at 0.657 SORL1 Sortilin-related receptor precursor (sorting protein-related
receptor containing LDLR class A repeats)
Ssc.5404.1.S1_at 0.657 MOSPD1 Motile sperm domain-containing 1 (Homo sapiens)
Ssc.27060.1.A1_at 0.656 SSSCA1 Sjogren’s syndrome/scleroderma autoantigen 1 (autoantigen
p27).
Ssc.26553.1.S1_at 0.655 AP1-c1 Adaptor-related protein complex 1 c1 subunit (c-adaptin)
(adaptor protein complex AP-1 c1 subunit)
Ssc.3656.1.S1_at 0.654 KHLX Kelch-like protein X (Homo sapiens)
Ssc.24239.1.S1_at 0.653 C10orf45 PREDICTED: Pan troglodytes hypothetical protein LOC737061
Ssc.9314.2.S1_at 0.653 TP53RK TP53 regulating kinase
Ssc.17314.1.S1_at 0.653 C3orf10 Probable protein BRICK1
Ssc.16057.2.S1_a_at 0.650 GANC Calpain 3 (EC 3.4.22.-) (Calpain L3)
Ssc.2756.1.A1_at 0.650 MRPL22 Mitochondrial ribosomal protein L22 (Homo sapiens)
Ssc.26084.1.S1_at 0.649 ATP2B1 Plasma membrane calcium-transporting ATPase 1
Ssc.8283.1.A1_at 0.649 PTPN11 Protein-tyrosine phosphatase, non-receptor type 11
Ssc.26735.1.A1_at 0.649 Q96BP3 Peptidylprolyl isomerase domain and WD repeat containing 1
(Bos taurus)
Ssc.8430.1.A1_at 0.649 Q86W74 Ankyrin repeat domain 46 (ANKRD46) (Bos taurus)
Ssc.1441.1.S1_at 0.649 DCTN3 Dynactin 3 isoform 1; dynactin light chain (Homo sapiens)
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Ssc.10542.1.S1_at 0.647 EXOSC1 39A59 ExoRNase CSL4 homologue
Ssc.772.1.S1_at 0.643 CARHSP1 Calcium-regulated heat-stable protein 1
Ssc.3281.1.S1_at 0.643 C11orf10 UPF0197 protein C11orf10 (HSPC005)
Ssc.16495.1.A1_at 0.643 DF5L Gasdermin domain containing protein 1 (Homo sapiens)
Ssc.4306.1.A1_at 0.642 MESDC1 Mesoderm development candidate 1
Ssc.26318.1.S1_at 0.638 DNCL1 Dynein light chain 1, cytoplasmic
Ssc.24811.1.A1_at 0.638 Q6NSI4 Nuclear receptor-binding protein 2 (NRBP2) (Bos taurus)
Ssc.1153.1.A1_at 0.638 C9orf28 C9orf28 protein
Ssc.22634.1.S1_at 0.637 RB1CC1 Rb1-inducible coiled-coil protein 1 (Homo sapiens)
Ssc.19778.1.S1_at 0.633 TNF-aIP8L2 Tumour necrosis factor-a-induced protein 8-like 2 (Bos taurus)
Ssc.8604.1.A1_at 0.631 SNX24 Sorting nexin 24 (SBBI31)
Ssc.5353.1.S1_at 0.627 ZDHHC3 Zinc finger DHHC domain-containing protein 3
Ssc.3154.1.S1_at 0.627 GRM5 Metabotropic glutamate receptor 5 precursor (mGluR5)
Ssc.6833.1.S1_at 0.625 BTG1 B-cell translocation protein 1 (Homo sapiens)
Ssc.1160.1.S1_at 0.624 PSMC3 26S protease regulatory subunit 6A (TAT-binding protein 1)
(TBP-1) (proteasome subunit P50)
Ssc.12944.1.A1_at 0.623 RPA3 Replication protein A 14 kDa subunit
Ssc.10037.1.A1_at 0.622 NLK Serine/threonine kinase NLK
Ssc.22120.1.S1_a_at 0.617 RYR2 PREDICTED: similar to RIKEN cDNA 3110009E18 (Homo
sapiens)
Ssc.18253.1.S1_at 0.616 F8 Coagulation factor VIII precursor
Ssc.24739.1.A1_at 0.616 SLC16A7 Monocarboxylate transporter 2 (MCT 2)
Ssc.16936.2.S1_a_at 0.615 Q9P0T8 Similar to hypothetical protein HSPC111 (Bos taurus)
Ssc.16691.1.S1_at 0.609 H2AF-J H2A histone family, member J isoform 1 (Homo sapiens)
Ssc.30182.1.A1_at 0.607 RER1 RER1 protein (Homo sapiens)
Ssc.21559.1.S1_at 0.606 ANKRD10 Ankyrin repeat domain protein 10
Ssc.11369.1.S1_at 0.605 NP_077271 Derlin-1 (Der1-like protein 1)
Ssc.1029.1.S1_at 0.603 PHF6 PHD finger protein 6 (PHD-like zinc finger protein)
Ssc.13954.1.A1_at 0.602 Q5VV17 PREDICTED: similar to hypothetical protein DKFZp761A052
Ssc.11878.1.S1_at 0.601 HMBS Porphobilinogen deaminase
Ssc.16677.1.S1_a_at 0.599 C17orf37 Uncharacterized protein C17orf37 (protein C35) (HBV X-
transactivated gene 4 protein)
Ssc.24943.1.S1_at 0.597 NDUFA11 NADH-ubiquinone oxidoreductase subunit B14.7
Ssc.3426.1.A1_at 0.595 MAPK6 Mitogen-activated protein kinase 6
Ssc.21783.1.S1_at 0.595 MRPL2 Mitochondrial ribosomal protein L2 (Homo sapiens)
Ssc.13370.1.A1_at 0.595 Q8NA66 RIKEN cDNA 1810054D07 gene (1810054D07Rik) (Mus muscu-
lus)
Ssc.1206.1.A1_at 0.595 ADAMTS19 ADAMTS-19 precursor
Ssc.6979.1.A1_at 0.587 TPP2 Tripeptidyl-peptidase II
Ssc.13218.1.A1_at 0.587 NP_660155 Testis development protein NYD-SP29 (Homo sapiens)
Ssc.19975.1.S1_at 0.582 TEBP Telomerase-binding protein p23 (Hsp90 co-chaperone) (Homo
sapiens)
Ssc.16392.2.A1_a_at 0.574 MKNK2 MAP kinase-interacting serine/threonine kinase 2
Ssc.6230.2.A1_at 0.573 SDCCAG3 Serologically defined colon cancer antigen 3 (Homo sapiens)
Ssc.21987.1.A1_at 0.57 IFRD1 IFN-related developmental regulator 1
Ssc.5163.1.S1_at 0.569 GCNT2 N-Acetyllactosaminide b-1,6-N-acetylglucosaminyl-transferase
Ssc.6189.1.A1_at 0.565 SLC7A11 Cystine/glutamate transporter (amino acid transport system xc
2)
Ssc.1333.1.A1_at 0.565 ZCCHC11 Zinc finger, CCHC domain containing 11 isoform b
Ssc.29047.1.S1_at 0.561 HIG2 Hypoxia-inducible protein 2 (Homo sapiens)
Ssc.22287.1.S1_at 0.561 GABR-a3 c-Aminobutyric-acid receptor a-3 subunit precursor [GABA(A)
receptor]
Ssc.2354.1.S1_at 0.554 GPR160 Probable G protein-coupled receptor 160
Ssc.4004.1.A1_at 0.552 SYNE2 Nesprin 2 (nuclear envelope spectrin repeat protein 2)
Ssc.13400.2.S1_at 0.550 C3orf4 Protein C3orf4 (membrane protein GENX-3745)
Ssc.26309.1.A1_at 0.548 CHES1 Checkpoint suppressor 1 (Forkhead box protein N3)
Ssc.6513.1.S1_at 0.542 LRRC28 Leucine-rich repeat-containing 28 (Homo sapiens)
Ssc.3451.1.S1_at 0.540 SLC11A2 Natural resistance-associated macrophage protein 2 (NRAMP2)
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http://vir.sgmjournals.org 2555genes (IFIT1, GBP1, USP18 and cig5) that encode accessory
proteins related to the immune response, and in particular
to the pro-inflammatory cytokine IFN-b, but also genes
with a known anti-apoptotic function (ADM and TNF-
aIP3).
At 12 h p.i., the downregulated transcripts were also largely
predominant over the upregulated ones (80 vs 20,
respectively). The latter confirmed the main pattern of
anti-apoptotic and antiviral response already observed at
9 h p.i., with the addition of two new transcripts
representing TNF-a and IL-10. The overall highest fold
change (FC) was observed for IFN-b (FC520.15 at 12 h
p.i.), whilst the most downregulated transcript was
NP_060114 (FC50.306 at 12 h p.i.). NP_060114 corres-
ponds to the human DRE1 protein, a member of the kelch-
repeat family, which modulates host immune response to
viral infection (Prag & Adams, 2003). KHLX belongs to the
same family and also showed a consistent downregulation
at 12 h (FC50.654).
The GO analysis assigned the 100 differentially expressed
transcripts at 12 h p.i. to 34 biological processes, five
molecular functions and three cellular components
Table 1. cont.
Affymetrix probe set ID Fold change Gene symbol Gene description
Ssc.4462.1.S1_at 0.536 SDHC Succinate dehydrogenase cytochrome b560 subunit, mitochon-
drial precursor (integral membrane protein CII-3)
Ssc.14114.1.A1_at 0.525 ABCD3 ATP-binding cassette, subfamily D, member 3 (70 kDa peroxi-
somal membrane protein) (PMP70)
Ssc.16563.1.S1_at 0.513 NP_067050 DC2 protein (Homo sapiens)
Ssc.1527.1.A1_at 0.503 SLC20A1 Solute carrier family 20 (phosphate transporter), member 1; Glvr-
1; PiT-1; gibbon ape leukemia virus receptor 1 (Homo sapiens)
Ssc.16475.1.S1_at 0.475 COL4-a3 Collagen a3(IV) chain precursor (Goodpasture antigen)
Ssc.17091.2.A1_s_at 0.463 C3orf52 TPA-induced transmembrane protein
Ssc.4472.1.A1_at 0.459 NXT2 NTF2-related export protein 2 (p15-2 protein) (DC9) (BM-025)
Ssc.15559.1.A1_s_at 0.306 NP_060114 DRE1 protein (Homo sapiens)
Fig. 2. (a) Distribution of signal intensities of the 100 transcripts differentially expressed at 12 h p.i. over the period of infection.
Left, control PAMs; right, infected PAMs. Each line represents a transcript. (b) Hierarchical clustering of the different time point
conditions, based on the transcripts differentially expressed at 12 h p.i. in control (C) and infected (I) PAMs. Coloration in both
figures refers to the condition of infected cells at 12 h p.i. and is directly proportional to the expression, ranging from red (high
expression) to green (low expression).
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(response to stimulus, response to stress and immune
response) effectively representing the general pattern of cell
response to infection. This was independently confirmed
by assigning the same 100 transcripts to regulatory
pathways using the Kyoto Encyclopedia of Genes and
Genomes (KEGG) database. The most represented path-
ways were all related to the immune response and included
mitogen-activated protein kinase (MAPK), JAK–STAT,
natural killer cell-mediated cytotoxicity, T-cell receptor
signalling, cytokine–cytokine receptor interaction and Toll-
like receptor signalling (data not shown).
Validation of the microarray data by real-time
PCR
The genes tested by real-time PCR (see Supplementary
Table S1) were selected to validate the microarray results
and to confirm the involvement of key biological pathways.
The set included the differentially expressed genes IFN-b,
cig5, TNF-a, TNF-aIP3, IL-10, USP18 and GRP58, as well
as three additional genes selected from recent literature
(IFN-a, IFN-aR1 and sialoadhesin), which were represented
on the array but had not shown differential expression
(Table 3). Pearson’s correlation coefficient (r) showed that
both the microarray and real-time PCR data were highly
correlated for the genes modulated between 6 and 12 h p.i.,
with a high consistency between pools and with r values
ranging from 0.95 (IFN-b) to 0.88 (USP18 and IL-10)
(Table 3). Only GRP58, shown by microarrays to be
upregulated at 1 h p.i. but downregulated at 6 h p.i.,
showed inconsistencies between pools and a very poor r
value.
Real-time PCR confirmed that IFN-b was the most
upregulated gene, whilst IFN-a was not differentially
expressed between control and infected cells at 9 and
12 h p.i. Moreover, real-time PCR analysis of PAMs in an
independent challenge experiment, with a different viral
strain and lower m.o.i., confirmed that, at 24 h p.i., IFN-b
was strongly induced whilst IFN-a was only slightly
upregulated (data not shown). The expression of IFN-b
increased together with the PRRSV titre, as affirmed by
PRRSV ORF7 gene expression (Fig. 3). Interestingly, real-
time PCR at 3 h p.i. showed a small but significant peak in
IFN-b and IFN-a expression, which was not detected by
microarrays. IFN-aR1 was confirmed not to be differenti-
ally expressed. Statistically significant differences in values
of sialoadhesin expression were found between infected and
control samples, but this was inconsistent between pools.
DISCUSSION
The finding that the only gene to be upregulated at 6 h p.i.
was a host RNA-dependent helicase (DDX17) indicates that
PRRSV does not induce a generalized suppression of host
gene transcription. This confirms and reinforces previous
observations (Zhang et al., 2000), showing enhanced
production of a cellular helicase (RHIV-1) in macrophages
in response to PRRSV infection. Other RNA viruses, such
as poliovirus and vesicular stomatitis virus, replicating
exclusively in the cytoplasm using virus-encoded RNA-
dependent RNA polymerases and thus not requiring the
host transcriptional apparatus, inhibit nuclear transcrip-
tion of cellular RNA polymerases (Weidman et al., 2003).
This transcription shut-off not only allows the virus to
evade cellular responses, but also may favour viral RNA
replication by increasing the pool of free ribonucleotides in
the cell. The complex expression pattern revealed by the
microarrays might suggest that PRRSV blocks specific
cellular transcription processes while upregulating others
that are potentially beneficial for virus replication. By
having a regulatory effect on cellular transcription, viruses
may promote their own replication while interfering with
the innate and adaptive immune responses that would
result in their removal.
The downregulation of four genes encoding mitochondrial
proteins (NP_060530, SDHC, MRPL2 and MRPL22)a t
different time points (6, 9 and/or 12 h p.i.) might add up
to the emerging role of mitochondria in antiviral
immunity. The mitochondrial antiviral signalling protein
MAVS is critical for the IFN-b signalling pathway in
response to dsRNA, and is required for both TLR3-
mediated and TLR3-independent signalling pathways, such
as that triggered by the RNA helicase RIGI (Moore et al.,
2008; Xu et al., 2005; Yoneyama et al., 2004). RIGI is the
product of DDX58, a member of the DEAD box family of
RNA helicases that mediate nucleoside triphosphate-
dependent unwinding of dsRNA and are involved in many
diverse cellular functions (Lamm et al., 1996). Intriguingly,
the only upregulated gene found by microarrays at 6 h p.i.
in PAMs (DDX17) belongs to the same family.
The atypical pattern of expression of innate immunity
genes indicates that PRRSV has probably developed
sophisticated mechanisms to control the antiviral response.
Indeed, only a subset (IFIT1, GBP1, USP18 and TNF-aIP3)
of genes commonly modulated by pathogens in response to
dsRNA and/or stimulated by IFN (Jenner & Young, 2005)
were found to be upregulated by PRRSV at 9 and/or 12 h
p.i. When the 1.5-fold change threshold was not applied
after ANOVA analysis, this subset also included CD44,
PML, PRKRA, CCl4, CCl8 and MT2A. Upregulation of
USP18 has been observed previously in PAMs following
PRRSV infection (Zhang et al., 1999). The same study
reported the upregulation of the antiviral gene MX1, but
neither MX1 nor MX2 was found to be differentially
expressed in the present investigation. Downregulation of
NRAMP2 at 12 h p.i. was consistent with the effects
observed previously in humans after human immunodefi-
ciency virus infection (reviewed by Jenner & Young, 2005).
Production of IFN-a and IFN-b is a well-known reaction of
virus-infected cells; however, only the IFN-b gene was
strongly upregulated by PRRSV in PAMs. The induction of
IFN-b mRNA, but not IFN-a mRNA, has also been
Macrophage genes modulated by PRRSV infection
http://vir.sgmjournals.org 2557Table 2. GO analysis and ranking of the 100 transcripts differentially expressed at 12 h p.i.
Ranking and assignment is given for the differentially expressed transcripts at 12 h p.i. to the three GO categories: biological process, molecular
function and cellular component. The number of transcripts for each process is shown, with the corresponding e-values.
GO category Ranking Number of transcripts e-value
Biological process
Response to stimulus 1 22 6.50610
24
Response to stress 2 14 6.10610
23
Immune response 3 11 6.60610
23
Physiological process 4 68 8.30610
23
Defence response 5 11 1.20610
22
Response to biotic stimulus 6 11 1.60610
22
Anion transport 7 5 2.00610
22
Regulation of apoptosis 8 7 2.30610
22
Regulation of programmed cell
death
9 7 2.40610
22
Meiosis 10 3 3.00610
22
M phase of meiotic cell cycle 11 3 3.00610
22
Macromolecule metabolism 12 34 3.10610
22
Meiotic cell cycle 13 3 3.10610
22
Organismal physiological process 14 16 3.60610
22
Anti-apoptosis 15 4 4.30610
22
M phase 16 5 4.40610
22
Inorganic anion transport 17 4 5.30610
22
Response to virus 18 3 5.40610
22
Negative regulation of apoptosis 19 4 6.00610
22
Negative regulation of pro-
grammed cell death
20 4 6.10610
22
Apoptosis 21 8 6.20610
22
Programmed cell death 22 8 6.30610
22
Activation of NF-kb transcription
factor
23 2 6.40610
22
Response to wounding 24 6 7.00610
22
Cell death 25 8 7.30610
22
Death 26 8 7.50610
22
Protein metabolism 27 25 7.60610
22
Negative regulation of cell prolif-
eration
28 4 7.80610
22
Positive regulation of transcription
factor activity
29 2 7.90610
22
Leukocyte adhesion 30 2 7.90610
22
B-cell proliferation 31 2 7.90610
22
Negative regulation of cellular
process
32 9 8.30610
22
Interaction between organisms 33 3 8.60610
22
Ion transport 34 8 9.20610
22
Molecular function
Antigen binding 1 3 1.50610
22
Receptor binding 2 8 6.00610
22
Phosphatase binding 3 2 8.70610
22
Tumour necrosis factor receptor
binding
4 2 8.70610
22
Cytokine activity 5 4 8.80610
22
Cellular component
Integral to membrane 1 26 6.90610
22
Intrinsic to membrane 2 26 7.10610
22
Extracellular space 3 6 8.80610
22
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Real-time PCR results of ten selected genes in two pools of PAMs infected with PRRSV (I) compared with control PAMs (C). The reported values are the means±SD of technical triplicates and
were calculated as described in Methods; values that significantly differ between infected and control PAMs are indicated in bold (*, P,0.10; **, P,0.05). The last column gives the Pearson’s
correlation coefficient (r) between real-time and microarray data.
Gene
symbol
Status Pool I Pool II r
1h 3h 6h 9h 1 2h 1h 3h 6h 9h 1 2h
IFN-b I 0.01±0.005 0.04±0.016* 0.01±0.006 0.13±0.032** 2.03±0.402** 0.01±0.003 0.05±0.011* 0.03±0.005 0.17±0.032** 2.76±0.556** 0.95
C 0.02±0.008 0.01±0.005* 0.004±0.002 0.01±0.002** 0.01±0.006** 0.01±0.005 0.01±0.007* 0.03±0.013 0.02±0.006** 0.03±0.01**
TNF-a I 4.02±1.614 1.37±0.467 0.3±0.106 0.25±0.072 1.16±0.425 5.95±2.325 1.76±0.679 0.59±0.102 0.89±0.236 2.55±0.728** 0.94
C 7.52±2.786 0.99±0.28 0.32±0.088 0.16±0.05 2.09±0.598 5.89±2.119 1.45±0.462 0.62±0.221 0.41±0.139 0.36±0.138**
TNF-aIP3 I 2.1±0.854 0.59±0.2 0.32±0.039 0.75±0.203** 1.31±0.4* 4.01±2.172 1.19±0.461 0.44±0.09 0.81±0.16** 3.17±1.232* 0.94
C 1.76±0.484 0.33±0.061 0.22±0.035 0.2±0.026** 0.42±0.12* 3.59±1.403 0.81±0.255 0.47±0.137 0.33±0.078** 0.24±0.071*
USP18 I 0.25±0.085 0.41±0.125 0.78±0.12 0.92±0.166* 1.61±0.393** 0.34±0.12 0.69±0.227 1.06±0.221 1.25±0.205* 2.37±0.868** 0.88
C 0.27±0.079 0.3±0.036 0.74±0.121 0.54±0.038* 0.53±0.106** 0.29±0.069 0.45±0.132 0.93±0.195 0.52±0.14* 0.44±0.123**
cig5 I 0.13±0.019 0.48±0.065 0.97±0.183 0.91±0.083* 1.72±0.102** 0.15±0.021 1.16±0.290 1.15±0.192 1.33±0.274** 2.37±0.137** 0.89
C 0.14±0.019 0.50±0.102 0.79±0.151 0.58±0.123* 0.86±0.258** 0.11±0.031 0.88±0.116 0.90±0.180 0.40±0.054** 0.45±0.164**
IL-10 I 0.62±0.228 0.52±0.199 0.19±0.094 0.49±0.151 1.6±0.415* 1.08±0.246 0.68±0.14 0.38±0.074 0.67±0.166 2.05±0.567** 0.88
C 0.57±0.107 0.18±0.087 0.18±0.047 0.23±0.04 0.47±0.06* 1.17±0.294 0.43±0.119 0.45±0.196 0.44±0.091 0.7±0.177**
GRP58 I 1.92±0.103** 0.99±0.175* 0.66±0.144**1.82±0.248 2.22±0.307** 1.22±0.187 1.55±0.195* 1.28±0.088 0.66±0.042** 1.13±0.147 0.09
C 1.00±0.046** 1.61±0.179* 1.49±0.268**1.19±0.161 0.66±0.043** 1.31±0.166 0.92±0.123* 1.40±0.183 1.29±0.154** 1.16±0.126
IFN-a I 0.07±0.013 0.18±0.028** 0.03±0.002 0.09±0.012 0.13±0.020 0.05±0.002 0.16±0.023** 0.14±0.018 0.09±0.005** 0.14±0.022 –
C 0.08±0.015 0.03±0.002** 0.03±0.002 0.06±0.013 0.08±0.013 0.05±0.004 0.04±0.004** 0.11±0.007 0.04±0.005** 0.11±0.004
IFN-aR1 I 0.93±0.274 0.96±0.239 0.91±0.165 0.85±0.187 0.87±0.25 1.01±0.139 1.06±0.115 1.10±0.035 1.19±0.10 0.95±0.151 –
C 1.11±0.450 1.096±0.265 1.12±0.220 0.84±0.202 1.02±0.192 1.06±0.129 1.06±0.114 0.96±0.133 1.20±0,128 1.06±0.058
Sialoadhesin I 0.25±0.016** 0.17±0.019 0.14±0.009 0.19±0.026 0.22±0.034 0.19±0.017 0.19±0.016 0.21±0.010 0.27±0.048* 0.46±0.071* –
C 0.17±0.033** 0.16±0.018 0.15±0.005 0.23±0.051 0.15±0.024 0.18±0.008 0.21±0.015 0.22±0.020 0.18±0.025* 0.28±0.010*
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9observed in monocyte-derived dendritic cells infected by
PRRSV at 12 h p.i. (Loving et al., 2007). Previous studies,
both in vitro and in vivo, have also shown that PRRSV is a
poor inducer or even a suppressor of IFN-a compared with
other respiratory viruses (Albina et al., 1998; Buddaert et al.,
1998; Miller et al., 2004; van Reeth et al., 1999). Blocking
IFN-aproductionclearlyisbeneficialforPRRSVreplication,
as IFN-a can efficiently block replication when present
during infection (Delputte et al., 2007; Loving et al., 2007).
IFN-b can also protect macrophages against PRRSV
infection (Overend et al., 2007), but it has been suggested
that IFN-balonemaybenotsufficienttotriggertheadaptive
immune response (Loving et al., 2007). A recent report has
shown that in vitro stimulation of monocytes and macro-
phages with IFN-a induces expression of sialoadhesin, the
main PRRSV receptor in PAMs, and that treatment with
IFN-a before inoculation strongly increases PRRSV infec-
tion of monocytes (Delputte et al., 2007). In agreement with
this, in this study neither the gene encoding sialoadhesin nor
that encoding IFN-aR1 (IFN receptor 1) showed consistent
differential expression in infected cells.
Despite previous evidence that IFN-b expression by
infected cells mediates and potentiates apoptosis (Tanaka
et al., 1998), the present study showed a predominance of
transcripts leading to prolonged cell survival within 12 h of
infection (both upregulation of anti-apoptotic transcripts
and downregulation of pro-apoptotic genes). Upregulation
was observed for IL-10, ADM and TNF-aIP3. IL-10 has
been demonstrated to protect cells against apoptosis (Sieg
et al., 1996; Zhou et al., 2001). ADM has been shown
(Kubo et al., 1998) to be overproduced by macrophages
after inflammation and to modulate cytokine production
(specifically TNF-a); several different independent studies
support the fact that ADM is an anti-apoptotic peptide on
different cell types (Bi et al., 2007; Uzan et al., 2006; Yin
et al., 2004). TNF-aIP3 is a cytoplasmic zinc finger protein
that inhibits NF-kb activity and TNF-mediated pro-
grammed cell death (Li et al., 2006; Qin et al., 2006).
Downregulated genes included those encoding NLK, a
stimulator of apoptosis (Yasuda et al., 2003), HIF1-a,
which has been suggested to favour apoptosis in the
absence of oxygen (Bruick, 2000), and GRM5, known to
protect neurons from apoptotic death (Maiese et al., 2000).
Taken together, these findings suggest that PRRSV actively
induces an anti-apoptotic state in order to complete its
virus replication cycle. This is discordant with previous
results showing that PRRSV induces infected cells, as well
as uninfected bystander cells, to undergo apoptosis (for
examples, see Chang et al., 2005; Sirinarumitr et al., 1998),
but it should be noted that those data were obtained with
in vitro infection treatments much longer than 12 h. On
the other hand, the absence of apoptotic induction by
PRRSV has been observed in MARC-145 cells (Miller &
Fox, 2004) and HeLa cells (Lee et al., 2004). Interestingly,
Kim et al. (2002) reported an atypical form of apoptosis
that culminates in increased cell membrane permeability
and late apoptosis after completion of virus replication.
The upregulation of IL-10 gene expression (FC51.9)
indicates that the IL-10-mediated downregulation of the
T-helper cell type 1 (Th1) response may be an important
mechanism operated by PRRSV, as well as by other viruses
(for reviews, see Fickenscher et al., 2002; Redpath et al.,
2001). Upregulation of IL-10 expression was found
previously in PRRSV-infected porcine monocytes, macro-
phages and dendritic cells (Flores-Mendoza et al., 2008;
Suradhat et al., 2003) and in vivo in PRRSV-infected
pigs (Suradhat & Thanawongnuwech, 2003; Sutherland
et al., 2007; Thanawongnuwech & Thacker, 2003;
Thanawongnuwech et al., 2004). IL-10 in PRRSV-infected
cells seems to be increased concurrent with the onset of
viraemia and the development of clinical signs (Dı ´az et al.,
2005). Also, PIK3R1 (upregulated in this study: FC51.6),
is known to positively regulate the production of IL-10
(Saegusa et al., 2007). These findings add to previous
studies (Murtaugh et al., 2002; Wang et al., 2007),
suggesting that PRRSV causes an imbalanced immune
response characterized by an abundance of humoral
immunity (Th2-mediated), which is less effective against
viral pathogens.
The TNF-a gene was only slightly upregulated at 12 h p.i.
(FC51.5). The role of TNF-a in PRRSV infection is
controversial: it has been reported that PRRSV is a
potent inducer of TNF-a in PAMs at 18, 36, 54, 72, 90
and 108 h p.i. (Chang et al., 2005) and at 6 and 15 h p.i.
(Thanawongnuwech et al., 2004). However, Charer-
ntantanakul et al. (2006) showed that, in porcine mono-
cytes infected by PRRSV, IL-10 gene expression increased,
and this response contributed to a reduction in TNF-a
production. In fact, crucial anti-inflammatory activities of
IL-10 may be due to its inhibitory effects on TNF-a
production (Moore et al., 2001). Overall, this suggests that
IL-10 may also participate in fine-tuning the production
and effects of TNF-a.
Fig. 3. Comparison of the time-course expression of host IFN-b
and PRRSV ORF7 expression by real-time PCR in control (C) and
infected (I) PAMs at five time points p.i. Results are shown as
means±SD.
S. Genini and others
2560 Journal of General Virology 89Other differentially expressed genes (see Table 1) con-
firmed that a complex pattern of TNF-a regulation takes
place upon PRRSV infection. TNF-aIP3, known to be
induced by TNF-a (Dixit et al., 1990; Lee et al., 2000) and
suggested to protect against the inflammatory response to
influenza virus infection (Onose et al., 2006), was
upregulated. STAG2, an enhancer of TNF production
(Lara-Pezzi et al., 2004), and the member of the MAPK
pathway, ATF2, a transcription activator of both IFN-b and
TNF-a in response to virus infection (Biron & Sen, 2001;
Tsai et al., 1996), were downregulated. The MAPK pathway
was the most highly represented gene network identified in
this study, with five differentially expressed genes at 12 h
p.i. (ATF2, TNF-a, MAP3K8, MKNK2 and NLK). The
MAPK pathway is one of the most important pathways for
immune response to infection (Bruder & Kovesdi, 1997;
Yang et al., 2007) and has been found to be modulated in
PAMs after an antibody-mediated cross-linking treatment
of sialoadhesin, the main PRRSV internalization receptor
(Genini et al., 2008), although in this case different genes of
the pathway were involved.
In conclusion, this work has provided a genome-wide gene
expression catalogue of PRRSV pathogenesis and has
allowed us to picture how different genes and gene
pathways are co-modulated in the physiological context
of the PAM. As such, these results provide a large-scale and
unbiased basis for further investigations on gene roles and
functions. The sequencing of the pig genome currently in
progress (www.piggenome.org), besides allowing a com-
plete annotation of all transcripts, will soon give important
clues for future genomics studies, for example for the
interpretation of genome scan analyses aimed at identifying
the genetic components involved in PRRSV resistance/
susceptibility in swine populations (Ait-Ali et al., 2007;
Lewis et al., 2007).
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